SHANDONG BOAN BIOTECH-H

Shandong Boan Biotech-h trades -3.4 percent lower on Wednesday 28th of October

Explore Shandong Boan Biotech-H’s latest market performance—price, volume, 52‑week highs/lows, and its biotech focus on oncology and autoimmunity.

SHANDONG BOAN BIOTECH-H
China
Health Care
Pharmaceuticals, Biotechnology & Life Sciences
AI generated

Jake Connors

28/10/2026, 08:02

2 minutes to read

Shandong Boan Biotech-h trades 1.09 percent higher on Tuesday 27th of October

Shandong Boan Biotech-h hits HKD 3.12, up 17.85% MoM, with a 200‑day SMA at HKD 5.71 and a 52‑week high of HKD 11.20 – biotech investors eye its oncology‑focused antibody pipeline.

SHANDONG BOAN BIOTECH-H
China
Health Care
Pharmaceuticals, Biotechnology & Life Sciences
AI generated

Elliot Mercer

27/10/2026, 18:06

3 minutes to read